Tellgen (300642.SZ) Stock Price

Tellgen Price

CLOSED
18.50
​
Market closed

Over the last 13 years Tellgen grew revenue by 16.7% annually, reaching 363.83 M CNY. Earnings per share have declined at 9.8% per year over the last 13 years. For Tellgen, the net margin of 1.0% is down versus 24.6% a few years ago. At today's price the dividend yield works out to roughly 0.81%. The payout ratio is around 677% of earnings. The dividend has grown at 3.8% per year over the past 8 years. The consensus 12-month price target for Tellgen is 23.46 CNY, about 26.8% above where the stock trades today. Of 5 analysts, 4 rate the stock a buy — an overall Buy consensus.

Tellgen stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Tellgen business model & stock analysis

Tellgen Corp, headquartered in Shanghai, China, operates in the Health Care sector, specializing in the development, manufacturing, and marketing of molecular diagnostic products. The company employs 710 full-time staff and is listed on the stock market since 21 April 2017. Its product portfolio includes immunodiagnostic, molecular, and biochemical diagnostic solutions, such as tumor marker detection, HPV nucleic acid testing, autoimmune disease detection, and lung cancer methylation mutation detection systems.

Frequently asked questions about Tellgen

Analysts currently set an average price target of 23.46 CNY for the Tellgen stock (median: 23.46 CNY), implying +26.8 % versus the latest price. The consensus is based on 5 analyst ratings.

5 analysts currently rate the Tellgen stock: 4 recommend buying, 1 holding and 0 selling.

Converted at the current exchange rate, the Tellgen share trades at 2.46 EUR (18.50 CNY).

The expected revenue of Tellgen is 511.00 M CNY. This figure is based on current financial data and reflects the company's business performance.

The profit cannot currently be calculated for Tellgen.

The P/E ratio cannot be calculated for Tellgen at the moment.

The price-to-sales ratio (P/S) of Tellgen is currently 5.87. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Tellgen stock.

The Eulerpool Quality Score for Tellgen is 3/10.

The ISIN of Tellgen is CNE100002P42. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Tellgen is 300642.SZ. The ticker symbol is used to trade Tellgen shares on the stock exchange.

Fair ValueTerminal
18.50 CNY
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Equipment & Supplies
Number of shares
Employees
Revenue per Employee
512,435.21 CNY
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website tellgen.com
Country
Currency
CNY
Initial public offering
Apr 21, 2017
ISIN
CNE100002P42
Cusip
Y8T60Z104
Market capitalization
3.01 B CNYMid Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2026
—
P/S
P/Se
5.87
EV/EBIT
77.36
P/B Ratio
2.11
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
0.20 %
Dividend
Dividend yield
0.81 %
Est. Dividend Yield
0.81 %
Payout Ratio
677.40 %
Dividend growth Ø5Y
-9.71 %
Dividend payments per year
1
Dividend paid since
9 years
Dividend not reduced since
1 year
Dividend increased since
0 years
Dividend withholding tax
10.00 %
Last updated Oct 19, 2026, 6:13 PM

Tellgen Peer Group

Tellgen FIGI

300642:CH · BBG0058P2GV2300642:CS · BBG00G6XCR20

All fundamentals and in-depth analysis of Tellgen

Our stock analysis for Tellgen stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Tellgen. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.